2021

1. Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome–negative adult lymphoblastic leukemia

   Blood, Vol. 137, Núm. 14, pp. 1879-1894

2. Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trials

   Hematological Oncology, Vol. 39, Núm. 4, pp. 529-538